5'-aminolevulinate synthase 2
Senast uppdaterad 19 Sept 2025
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
The ALAS2 gene provides instructions for making an enzyme called 5-aminolevulinate synthase. This enzyme is found only in developing red blood cells called erythroblasts. The enzyme is located inside the energy-producing centers of these cells, which are called the mitochondria.
Videoval för GenesVideobibliotek
Normal function
The ALAS2 gene provides instructions for making an enzyme called 5-aminolevulinate synthase. This enzyme is found only in developing red blood cells called erythroblasts. The enzyme is located inside the energy-producing centers of these cells, which are called the mitochondria.
5-aminolevulinate synthase plays an important role in the production of heme. Heme is a component of iron-containing proteins called hemoproteins. The most abundant of these proteins is hemoglobin, which is the protein that carries oxygen in the blood. Heme is essential for many of the body's organs, and it is primarily found in the blood, bone marrow, and liver.
The production of heme is a multi-step process that requires several different enzymes. The 5-aminolevulinate synthase enzyme is responsible for the first step in this process. The enzyme uses vitamin B6 to form a compound called delta-aminolevulinic acid (ALA). In subsequent steps, other enzymes produce and modify compounds in a process that ultimately leads to heme production.
Conditions referring to this gene or chromosome
Other names
5-aminolevulinate synthase, erythroid-specific, mitochondrial
ALAS, erythroid
ALAS-E
aminolevulinate, delta-, synthase 2
ANH1
ASB
HEM0_HUMAN
Related patient information and medicines

Patient information leaflet
Aktinisk keratos
An actinic keratosis (also known as a solar keratosis) is the most common skin condition caused by sun damage. It is the result of skin being damaged by the sun over many years. It may be used alone or in a combination cream with fl... Photodynamic therapy Photodynamic therapy is an alternative to topical treatments. It is used in conjunction with.

Patient information leaflet
Typ 2-diabetesbehandling
If a high blood sugar level is brought down to a normal level, your symptoms will ease and your risk of long-term complications will be much lower. Managing type 2 diabetes Keeping your blood sugar (glucose) well controlled is key to reducing your risk of long-term complications such as heart, kidney or eye problems. See the leaflet that comes in.

Patient information leaflet
Kan jag ta järntillskott och Sedoxil tillsammans?
Taking iron supplements at the same time as Sedoxil (mexazolam) may reduce how much of the medication your body absorbs. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. ...fied healthcare professional before making decisions about your.

Patient information leaflet
Körtelfeber
Glandular fever (also known as infectious mononucleosis) is a viral infection that most often affects teenagers and young adults. Although it can make some people feel quite ill, full recovery is usual. What is glandular fever. Glandular fever is a viral infection, mostly caused by the Epstein-Barr virus. The virus can be passed from person to.

Patient information leaflet
Find out if you are eligible for a free NHS flu vaccination
Open the flu jab Is the flu vaccine free for you this winter. The flu vaccine is free on the NHS for people most likely to get seriously ill from flu, and for those who could easily pass it on to someone at risk. Whether you qualify depends on your age, your health, and a few other things such as being pregnant or caring for someone. The groups.

Patient information leaflet
Diabetes
There are two main types of diabetes - type 1 diabetes and type 2 diabetes. Type 2 u... However, type 2 diabetes is increasingly diagnosed in children and in young adults. Find out more here: [/health/diabetes-mellitus-leaflet](https://patient.info/health/diabetes-mellitus-leaflet) Diabetes mellitus (just called diabetes from.
Vidare läsning och referenser
- 5'-aminolevulinate synthase 2; MedlinePlus, National Library of Medicine.
- Astner I, Schulze JO, van den Heuvel J, Jahn D, Schubert WD, Heinz DW. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J. 2005 Sep 21;24(18):3166-77. doi: 10.1038/sj.emboj.7600792. Epub 2005 Aug 25.
- Cox TC, Sadlon TJ, Schwarz QP, Matthews CS, Wise PD, Cox LL, Bottomley SS, May BK. The major splice variant of human 5-aminolevulinate synthase-2 contributes significantly to erythroid heme biosynthesis. Int J Biochem Cell Biol. 2004 Feb;36(2):281-95. doi: 10.1016/s1357-2725(03)00246-2.
- Fujiwara T, Harigae H. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia. Free Radic Biol Med. 2019 Mar;133:179-185. doi: 10.1016/j.freeradbiomed.2018.08.008. Epub 2018 Aug 8.
- Jove-Solavera D, Ramila M, Ferrer-Cortes X, Olivella M, Venturi V, Morado M, Hernandez-Rodriguez I, Khan A, Perez-Montero S, Tornador C, Germing U, Gattermann N, Sanchez M. The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivation. Sci Rep. 2025 Apr 7;15(1):11843. doi: 10.1038/s41598-025-95590-x.
- Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol. 2008 May;15(3):169-75. doi: 10.1097/MOH.0b013e3282f73335.
- Shoolingin-Jordan PM, Al-Daihan S, Alexeev D, Baxter RL, Bottomley SS, Kahari ID, Roy I, Sarwar M, Sawyer L, Wang SF. 5-Aminolevulinic acid synthase: mechanism, mutations and medicine. Biochim Biophys Acta. 2003 Apr 11;1647(1-2):361-6. doi: 10.1016/s1570-9639(03)00095-5.
- Taylor JL, Ayres-Galhardo PH, Brown BL. Elucidating the Role of Human ALAS2 C-terminal Mutations Resulting in Loss of Function and Disease. Biochemistry. 2024 Jul 2;63(13):1636-1646. doi: 10.1021/acs.biochem.4c00066. Epub 2024 Jun 18.
- Taylor JL, Brown BL. Structural basis for dysregulation of aminolevulinic acid synthase in human disease. J Biol Chem. 2022 Mar;298(3):101643. doi: 10.1016/j.jbc.2022.101643. Epub 2022 Jan 28.
- Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet. 2008 Sep;83(3):408-14. doi: 10.1016/j.ajhg.2008.08.003. Epub 2008 Sep 4.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
19 Sept 2025 | Senaste versionen
1 Sept 2025 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

